But that doesn't mean it's useless for weight loss, far from it
The REWIND study evaluated the cardiovascular safety of dulaglutide (1.5 mg) in comparison to placebo ( Exenatide The EXSCEL (Exenatide Study of Cardiovascular Event Lowering) trial evaluated the CV safety of exenatide (2 mg weekly)
Furthermore, GLP-1s also have been shown to reduce cardiovascular risks, as well as potentially providing a range of other health benefits for patients with chronic kidney disease, gastrointestinal disorders, neurodegenerative diseases and psychiatric disorders
Conversely, if you're struggling to eat your protein target because appetite suppression is too strong, reduce the target slightly while ensuring you still hit a minimum of 0.7 grams per pound of goal body weight
With decades of experience helping patients in the region, they are the premier Reno weight loss center offering advanced medical solutions for long-term, sustainable weight management